Codexis (CDXS) EBIT (QoQ) (2010 - 2026)
Codexis (CDXS) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Codexis | 150.69 Mn | 95.77 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39.61% |
| Mar 31, 2026 | -176.17% |
| Dec 31, 2025 | 155.72% |
| Sep 30, 2025 | -47.33% |
| Jun 30, 2025 | 37.22% |
| Mar 31, 2025 | -179.06% |
| Dec 31, 2024 | 55.66% |
| Sep 30, 2024 | 27.16% |
| Jun 30, 2024 | -91.22% |
| Mar 31, 2024 | -4,330.60% |
| Dec 31, 2023 | 100.88% |
| Sep 30, 2023 | -153.92% |
| Jun 30, 2023 | 46.65% |
| Mar 31, 2023 | -78.60% |
| Dec 31, 2022 | -24.58% |
| Sep 30, 2022 | -307.67% |
| Jun 30, 2022 | 68.89% |
| Mar 31, 2022 | 19.25% |
| Dec 31, 2021 | -880.83% |
| Sep 30, 2021 | 129.65% |